67-6

28/93

Neurol. 2009; 65: 19-23. doi: 10.1002/ana.21415 [published Online First: 2008/06/24]29) Miki Y, Yoshizawa T, Morohashi S, et al: Neuropa-thology of PARK14 is identical to idiopathic Parkin-son’s disease. Mov Disord. 2017; 32: 799-800. doi: 10. 1002/mds.26952 [published Online First: 2017/02/18]30) Mori A, Hatano T, Inoshita T, et al: Parkinson’s disease- associated iPLA2-VIA/PLA2G6 regulates neuronal functions and alpha-synuclein stability through membrane remodeling. Proc Natl Acad Sci U S A. 2019; 116: 20689-99. doi: 10.1073/pnas.1902958116 [published Online First: 2019/09/25]31) Ballabio A, Bonifacino JS: Lysosomes as dynamic regu-lators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020; 21: 101-18. doi: 10.1038/s41580-019-0185-4 [published Online First: 2019/11/27]32) Platt FM, d’Azzo A, Davidson BL, et al: Lysosomal storage diseases. Nat Rev Dis Primers. 2018; 4: 27. doi: 10.1038/s41572-018-0025-4 [published Online First: 2018/10/03]33) Ysselstein D, Shulman JM, Krainc D: Emerging links between pediatric lysosomal storage diseases and adult parkinsonism. Mov Disord. 2019; 34: 614-24. doi: 10.1002/mds.27631 [published Online First: 2019/02/07]34) Grabowski GA: Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. 2008; 372: 1263-71. doi: 10. 1016/S0140-6736(08)61522-6 [published Online First: 2008/12/20]35) Neudorfer O, Giladi N, Elstein D, et al: Occurrence of Parkinson’s syndrome in type I Gaucher disease. QJM. 1996; 89: 691-4. [published Online First: 1996/09/01]36) Foo JN, Liany H, Bei JX, et al: Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkin-son’s disease. Neurobiol Aging. 2013; 34: 2890 e13-5. doi: 10.1016/j.neurobiolaging.2013.06.010 [published Online First: 2013/07/23]37) Dagan E, Schlesinger I, Ayoub M, et al: The contribu-tion of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews. Parkinsonism Relat Disord. 2015; 21: 1067-71. doi: 10.1016/j.parkreldis.2015.06.016 [published Online First: 2015/07/15]38) Suzuki K, Iseki E, Katsuse O, et al: Neuronal accumu-lation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model. Neuroreport. 2003; 14: 551-4. doi: 10.1097/00001756-200303240-00004 [published Online First: 2003/03/27]53639) Hill CH, Cook GM, Spratley SJ, et al: The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure. Nat Commun. 2018; 9: 151. doi: 10.1038/s41467-017-02361-y [published Online First: 2018/01/13]40) Sandhoff K: Metabolic and cellular bases of sphingolip-idoses. Biochem Soc Trans. 2013; 41: 1562-8. doi: 10. 1042/BST20130083 [published Online First: 2013/11/22]41) Tylki-Szymanska A, Czartoryska B, Vanier MT, et al: Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet. 2007; 72: 538-42. doi: 10.1111/ j.1399-0004.2007.00899.x [published Online First: 2007/ 10/09]42) Lefrancois S, May T, Knight C, et al: The lysosomal transport of prosaposin requires the conditional inter-action of its highly conserved d domain with sphingo-myelin. J Biol Chem. 2002; 277: 17188-99. doi: 10.1074/jbc.M200343200 [published Online First: 2002/02/22]43) Ross CA, Poirier MA: Protein aggregation and neuro-degenerative disease. Nat Med. 2004; 10 Suppl: S10-7. doi: 10.1038/nm106644) Braak H, Del Tredici K, Rub U, et al: Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003; 24: 197-211. [published Online First: 2002/12/25]45) Svensson E, Horvath-Puho E, Thomsen RW, et al: Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015; 78: 522-9. doi: 10.1002/ana.2444846) Liu B, Fang F, Pedersen NL, et al: Vagotomy and Parkinson disease: A Swedish register-based matched- cohort study. Neurology. 2017; 88: 1996-2002. doi: 10. 1212/WNL.0000000000003961 [published Online First: 2017/04/28]47) Luk KC, Kehm VM, Zhang B, et al: Intracerebral inoc-ulation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucle-inopathy in mice. J Exp Med. 2012; 209: 975-86. doi: 10. 1084/jem.20112457 [published Online First: 2012/04/18]48) Okuzumi A, Kurosawa M, Hatano T, et al: Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment. Acta Neuropathol Commun. 2018; 6: 96. doi: 10.1186/s40478-018-0587-0 [published Online First: 2018/09/21]49) Poewe W, Seppi K, Tanner CM, et al: Parkinson disease. Nat Rev Dis Primers. 2017; 3: 17013. doi: 10. 1038/nrdp.2017.13